The largest database of trusted experimental protocols

Control vector

Manufactured by OriGene
Sourced in United States

Control vectors are plasmid DNA constructs used as reference standards in various molecular biology experiments. They serve as a point of comparison to evaluate the performance and integrity of experimental samples. Control vectors typically contain a known DNA sequence and may include markers such as antibiotic resistance genes or reporter genes. These vectors are designed to provide a consistent and reliable benchmark for assessing the success of experimental procedures.

Automatically generated - may contain errors

7 protocols using control vector

1

Lentiviral Overexpression and Knockdown of GRP78

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human GRP78 overexpression lentivirus vector, GRP78 shRNA lentivirus vector, and control vector were purchased from Origene Technologies (Rockville, MD, USA). Cells (293) were transfected with either GRP78 overexpression, GRP78 shRNA, or control vector for producing lentivirus to infect HeLa cells. After 48 h of transfection, lentivirus was harvested and used for infecting HeLa cells. Expression of GRP78 was measured by Western blotting in each group to validate infection success.
+ Open protocol
+ Expand
2

Overexpression and Knockdown of SMO in 424GC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse SMO overexpression lentivirus vector, shRNA lentivirus vector, and control vector were purchased from Origene (Rockville, MD, USA). We transfected 293 cells with either overexpression, shRNA, or control vector for producing lentivirus to infect 424GC cells. The lentivirus particles were used for infecting 424GC cells. Expression of SMO were measured by Western blot analysis in each group.
+ Open protocol
+ Expand
3

Breast Cell Line Cultures and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nonmalignant (MCF10A, MMuMG) and malignant (MDA‐MB‐468, MCF‐7 and MDA‐MB‐231) breast cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). Nonmalignant breast cell lines were cultured in mammary epithelial cell growth medium with supplements (Lonza, Walkersville, MD, USA), and malignant breast cell lines were cultured in RPMI 1640 medium (Thermo Scientific, Rockford, IL, USA) supplemented with 10% FBS (Gibco, Gaithersburg, MD, USA) at 37 °C in an atmosphere of 95% air and 5% CO2.
Stable cell lines of MDA‐MB‐231 were generated by integration of retroviral shRNA vectors specific for GHR or a control vector from OriGene (Rockville, MD, USA).
+ Open protocol
+ Expand
4

Quantifying TRPA1 Expression in DRG Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice at 4–6 weeks of age were killed with CO2 and DRGs were quickly collected in cold PBS after removing axons and meningeal tissue and digested for 30 min at 37 °C in trypsin, collagenase and DNAse. Neurons were plated on poly-L-lysine coated coverslip and cultured in Neurobasal medium plus B27 and N2 supplement (Gibco) without adding growth factors or mitotic inhibitor. At 18–20 h after plating, cultured DRG neurons were transfected using the calcium phosphate method with the following plasmids: ORF of mouse TRPA1 C- terminally myc-tagged (a kind gift from Manuela Schmidt, Max Planck Institute für Experimentelle Medizin, Göttingen), or a control vector (Origene Inc.).
At 24 h after transfection, the cells were treated with Sema4C (see above) for 15 min, washed and fixed in 4% PFA for 20 min at room temperature. Immunofluorescence analysis was performed using an anti-myc antibody (mouse (9E10) 1:1000, sc-40 Santa Cruz) anti-β-tubulin III (rabbit 1: 1000; T2200, Sigma) and secondary antibodies conjugated with Alexa488 or Alexa 594 (Molecular Probes, Invitrogen) using standard protocols. The relative levels of TRPA1 expression at the cell membrane vs. cytoplasm were analyzed using the line profile tool in confocal microscopy (Leica TCS AOBS), or Fiji software.
+ Open protocol
+ Expand
5

Cell Line Generation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, H1299, HCT116, HeLa, and PC9 were purchased from ATCC (USA). All cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) or RPMI-1640 medium with 10% fetal bovine serum (FBS) and 100 μg/ml penicillin/streptomycin. HCT116 shN and HCT116 shR cells were constructed previously. H1299 shN, H1299 shR, PC9 shN, and PC9 shR cells were generated by stable integration of a retroviral shRNA vector specific for REGγ or a control vector from OriGene (Rockville, MD). H1299 shN & H1299 shR cells stably expressing NIP30 WT, NIP30 4A, or NIP30 4D were generated in our laboratories. 293T-REGγ knockout cells were generated using TALENs. 293T & 293T KO cells with stable expression of NIP30 (221–235) WT or NIP30 (221–235) 4A or NIP30 (221–235) 4D were also generated for this study. The 293-REGγ inducible cell lines were previously described1 (link).
+ Open protocol
+ Expand
6

Establishing cell lines for HK2 overexpression and knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection was conducted using the Lipofectamine 3000 reagent (Invitrogen) according to the manufacturer’s instructions. The control vector, HK2 overexpression vector, control shRNA, or HK2 shRNA was obtained from OriGene and Santa Cruz Biotechnology, respectively. Control siRNA, HK2 siRNA, control mimic, miR-145 mimic, miR-148a mimic, miR-497 mimic, control inhibitor, miR-145 inhibitor, miR-148a inhibitor, or miR-497 inhibitor, was purchased from Invitrogen. When cells achieved 70% confluence, the above plasmid, shRNA, siRNA, or miRNA mimic (or inhibitor) was transfected into CC cells for 48 h. Finally, stable HK2-overexpressing or HK2 knockdown CC cell lines were established by selecting cells using G418 (Sigma-Aldrich) or Puromycin (Sigma-Aldrich) for 4 weeks.
+ Open protocol
+ Expand
7

Transfection of miRNA-330 Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The vector carrying miRNA-330 gene, as an expression plasmid for human microRNA-330 and control vector (empty vector without miRNA gene) were obtained from Origene (USA). Transfection was applied with jetPEI® solution (Polyplus, France) based on the protocol description.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!